|
Real-time Estimate
Cboe BZX
17:47:34 17/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 14.88 USD | +1.19% |
|
+0.13% | +5.98% |
| 03:43pm | Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Tuesday Trading | MT |
| 11-16 | Gilead signs generic licensing deals for experimental Ebola drug | RE |
| Market Cap | 1,155B 12.37B 11.23B 10.37B 9.36B 17.66B 18.34B 125B 49.43B 624B 46.4B 45.42B 1,970B | P/E 2027 * |
31.5x | P/E 2028 * | 23.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1,125B 12.04B 10.93B 10.1B 9.11B 17.2B 17.86B 122B 48.13B 607B 45.19B 44.23B 1,918B | EV / Sales 2027 * |
3.2x | EV / Sales 2028 * | 2.81x |
| Free-Float |
68.54% | Yield 2027 * |
0.54% | Yield 2028 * | 0.6% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| RDY | Delayed | |
| RDY | Real-time | ||
| RDDA | Real-time | ||
| RDDA | Delayed | ||
| RDDA | Delayed | ||
| RDDA | Real-time |
Last Transcript: Dr. Reddy's Laboratories Limited
| 1 day | +1.19% | ||
| 1 week | +0.13% | ||
| Current month | +5.01% | ||
| 1 month | +13.76% | ||
| 3 months | +22.87% | ||
| 6 months | +9.41% | ||
| Current year | +5.98% |
| 1 week | 14.6 | 14.94 | |
| 1 month | 13.02 | 15.08 | |
| Current year | 11.36 | 15.67 | |
| 1 year | 11.36 | 15.67 | |
| 3 years | 11.36 | 16.89 | |
| 5 years | 9.58 | 16.89 | |
| 10 years | 5.63 | 16.89 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 59 | 30/06/2019 |
| Director of Finance/CFO | - | 31/07/2024 | |
Sanjay Sharma
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 12/05/2014 | |
Gunupati Prasad
CHM | Chairman | 65 | 01/04/2013 |
Leo Puri
BRD | Director/Board Member | 65 | 24/10/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.19% | +0.13% | - | - | 12.24B | ||
| -1.02% | -1.11% | +38.63% | +139.37% | 1,275B | ||
| -0.79% | -0.06% | +40.60% | +87.33% | 680B | ||
| -0.42% | -0.27% | +25.26% | +111.93% | 521B | ||
| -0.76% | +1.10% | +41.43% | +70.96% | 389B | ||
| -0.25% | -2.80% | +54.98% | +41.43% | 356B | ||
| -1.83% | -0.89% | +26.00% | +58.48% | 305B | ||
| -1.65% | -0.59% | +1.55% | +34.52% | 287B | ||
| -0.62% | -1.33% | +34.33% | +72.96% | 250B | ||
| +1.77% | -0.43% | +37.11% | +125.50% | 208B | ||
| Average | -0.57% | +0.51% | +33.32% | +82.50% | 475B | |
| Weighted average by Cap. | -0.87% | +0.76% | +35.21% | +95.95% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 351B 3.76B 3.41B 3.15B 2.84B 5.37B 5.58B 38B 15.03B 190B 14.11B 13.81B 599B | 393B 4.21B 3.82B 3.53B 3.18B 6.01B 6.24B 42.54B 16.83B 212B 15.79B 15.46B 671B |
| Net income | 36.52B 391M 355M 328M 296M 558M 580M 3.95B 1.56B 19.71B 1.47B 1.44B 62.26B | 49.32B 528M 479M 443M 399M 754M 783M 5.33B 2.11B 26.61B 1.98B 1.94B 84.08B |
| Net Debt | -30.25B -324M -294M -272M -245M -462M -480M -3.27B -1.29B -16.32B -1.21B -1.19B -51.58B | -49.45B -529M -480M -444M -400M -756M -785M -5.35B -2.12B -26.69B -1.99B -1.94B -84.31B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/11/26 | US$14.88 | +1.22% | 609,005 |
| 16/11/26 | US$14.70 | -0.27% | 1,232,011 |
| 13/11/26 | US$14.74 | +0.07% | 3,713,807 |
| 12/11/26 | US$14.73 | -0.74% | 1,654,035 |
| 11/11/26 | US$14.84 | -0.13% | 2,176,818 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- DRREDDY Stock
- RDY Stock
Select your edition
All financial news and data tailored to specific country editions

















